Sherry Kit Wa Chan, MD, is affiliated with the Department of Psychiatry and the State Key Laboratory of Brain and Cognitive Sciences at The University of Hong Kong. Chan has published extensively on schizophrenia and schizoaffective disorders, including studies on symptomatic remission and cognitive impairment in first-episode schizophrenia. Research topics also encompass suicide risk and its seasonal variation, as well as the impact of pandemics on social cohesion and suicide rates. Chan's work includes investigations into the clinical utility and barriers to clozapine use.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
